2021 Midyear Review: Non–Small-Cell Lung Cancer

Every year, researchers and clinicians report on exciting advancements in the diagnosis and treatment of cancer. In 2021, despite the COVID-19 pandemic, developments in the management of lung cancer continue to be important and intriguing.

Annual congresses, such as the American Association of Cancer Research (AACR) 2021 and the American Society of Clinical Oncology (ASCO) 2021, continue to be held via Internet-based video and audio links due to the COVID-19 pandemic. Despite this, hundreds of posters and presentations were shared.

Based on presentations from AACR and ASCO, here are some of the most important data that are likely to affect the care of patients with metastatic non–small-cell lung cancer in the months and years to come.

Related Items

Conference Correspondent Coverage is Brought to You by the Publishers of:
American Health & Drug Benefits
CONQUER: the patient voice
Journal of Hematology Oncology Pharmacy
Journal of Oncology Navigation & Survivorship
Oncology Practice Management
Personalized Medicine in Oncology
The Oncology Nurse–APN/PA
The Oncology Pharmacist
Value-Based Cancer Care

Learn more about our family of publications.

View Our Publications